Throughout his career Dr. Azziz has served as an effective and passionate executive, administrator, leader and advocate in the areas of academic medicine, clinical & translational sciences, higher education, and healthcare.
Dr. Azziz is an international authority on reproductive medicine, endocrinology, and surgery, with recognized expertise in the study of androgen excess (AE) disorders in women, including polycystic ovary syndrome (PCOS) and 21-hydroxylase deficient non-classic adrenal hyperplasia (NCAH). Over the past 25 years he has developed a widely recognized research program, generating 500+ peer-reviewed articles, book chapters and reviews; 300+ abstracts and invited presentations; and nine texts, which has been extensively funded by the National Institutes of Health, among other agencies.
Discoveries are what good science starts with. For example, Dr. Azziz’s group was the first to discover that 5-15% of women suffer from PCOS. And that the high rate of obesity in PCOS may be a reflection of referral bias.
Improvements in healthcare begins when we translate new scientific findings to patient care. For example, Dr. Azziz’s team were the first to clearly describe the ability to screen for non-classic adrenal hyperplasia just by a morning blood test.
Better healthcare based on better science is improved when we educate all concerned: patients, physicians, other health professionals, government representatives, and research funding agencies. For example, Dr. Azziz is the Founder of the Androgen Excess & PCOS Society, Inc. dedicated to ensuring the education of the international community regarding these very common disorders.
Dr. Azziz is a long-term and dedicated educator. He is a passionate advocate for maximizing student success, enhancing diversity and inclusion on campus, leadership and young faculty development, and the training of health professionals.